Wnt surrogate molecules and uses thereof
US12297278B2 · kind B2 · utility
0Cited by
31References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 28, 2023 |
| Grant date | May 13, 2025 |
| Priority date | — |
| Expiry date | Jul 28, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/33
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides Wnt pathway agonists and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.